Business Description
Celltrion Inc
NAICS : 325411
SIC : 2834
ISIN : KR7068270008
Share Class Description:
XKRX:068270: Ordinary SharesCompare
Compare
Traded in other countries / regions
068270.Korea IPO Date
2005-07-19Description
Celltrion Inc is a Korea-based company principally engaged in the research, development, and manufacture of therapeutic proteins. The company mainly manufactures biosimilar products, which are used to treat breast cancer, rheumatoid arthritis disease, Crohn's disease, Hodgkin's lymphoma, colorectal cancer, rheumatoid arthritis, respiratory syncytial virus, colon cancer, and others.
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.43 | |||||
Equity-to-Asset | 0.84 | |||||
Debt-to-Equity | 0.13 | |||||
Debt-to-EBITDA | 2.61 | |||||
Interest Coverage | 18.04 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 8.02 | |||||
Beneish M-Score | -2.8 | |||||
WACC vs ROIC |
Growth Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 6.3 | |||||
3-Year EBITDA Growth Rate | 4 | |||||
3-Year EPS without NRI Growth Rate | 1.3 | |||||
3-Year Book Growth Rate | 52.1 | |||||
Future 3-5Y EPS without NRI Growth Rate | 35.51 | |||||
Future 3-5Y Total Revenue Growth Rate | 31.67 |
Momentum Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 76.55 | |||||
9-Day RSI | 70.55 | |||||
14-Day RSI | 65.89 | |||||
6-1 Month Momentum % | -2.96 | |||||
12-1 Month Momentum % | 24.16 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.84 | |||||
Quick Ratio | 0.8 | |||||
Cash Ratio | 0.32 | |||||
Days Inventory | 452.96 | |||||
Days Sales Outstanding | 256.88 | |||||
Days Payable | 16.57 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.25 | |||||
Dividend Payout Ratio | 0.19 | |||||
Forward Dividend Yield % | 0.25 | |||||
5-Year Yield-on-Cost % | 0.25 | |||||
3-Year Average Share Buyback Ratio | -13.4 | |||||
Shareholder Yield % | 0.86 |
Profitability Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 47.26 | |||||
Operating Margin % | 20.92 | |||||
Net Margin % | 16.96 | |||||
FCF Margin % | 2.75 | |||||
ROE % | 4.22 | |||||
ROA % | 3.33 | |||||
ROIC % | 3.71 | |||||
ROC (Joel Greenblatt) % | 14.36 | |||||
ROCE % | 5.22 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 73.74 | |||||
PE Ratio without NRI | 74.12 | |||||
Shiller PE Ratio | 70.35 | |||||
Price-to-Owner-Earnings | 220.73 | |||||
PEG Ratio | 4.49 | |||||
PS Ratio | 13.66 | |||||
PB Ratio | 2.44 | |||||
Price-to-Tangible-Book | 11.53 | |||||
Price-to-Free-Cash-Flow | 373.24 | |||||
Price-to-Operating-Cash-Flow | 69.38 | |||||
EV-to-EBIT | 83.94 | |||||
EV-to-Forward-EBIT | 30.02 | |||||
EV-to-EBITDA | 51.45 | |||||
EV-to-Forward-EBITDA | 24.87 | |||||
EV-to-Revenue | 18.47 | |||||
EV-to-Forward-Revenue | 13.02 | |||||
EV-to-FCF | 632.07 | |||||
Price-to-Projected-FCF | 2.78 | |||||
Price-to-DCF (Earnings Based) | 2.32 | |||||
Price-to-DCF (FCF Based) | 29.9 | |||||
Price-to-Median-PS-Value | 0.72 | |||||
Price-to-Peter-Lynch-Fair-Value | 4.52 | |||||
Price-to-Graham-Number | 6.16 | |||||
Price-to-Net-Current-Asset-Value | 20.89 | |||||
Earnings Yield (Greenblatt) % | 1.2 | |||||
FCF Yield % | 0.16 | |||||
Forward Rate of Return (Yacktman) % | 16.71 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Celltrion Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil â‚©) | 2,315,847.935 | ||
EPS (TTM) (â‚©) | 2712 | ||
Beta | 0.6 | ||
Volatility % | 31.72 | ||
14-Day RSI | 65.89 | ||
14-Day ATR (â‚©) | 5662.427325 | ||
20-Day SMA (â‚©) | 188485 | ||
12-1 Month Momentum % | 24.16 | ||
52-Week Range (â‚©) | 131000 - 241000 | ||
Shares Outstanding (Mil) | 207.53 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Celltrion Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Celltrion Inc Stock Events
Event | Date | Price(â‚©) | ||
---|---|---|---|---|
No Event Data |
Celltrion Inc Frequently Asked Questions
What is Celltrion Inc(XKRX:068270)'s stock price today?
The current price of XKRX:068270 is â‚©200000.00. The 52 week high of XKRX:068270 is â‚©241000.00 and 52 week low is â‚©131000.00.
When is next earnings date of Celltrion Inc(XKRX:068270)?
The next earnings date of Celltrion Inc(XKRX:068270) is 2024-08-14 Est..
Does Celltrion Inc(XKRX:068270) pay dividends? If so, how much?
The Dividend Yield %  of Celltrion Inc(XKRX:068270) is 0.25% (As of Today), Highest Dividend Payout Ratio of Celltrion Inc(XKRX:068270) was 0.19. The lowest was 0.1. And the median was 0.14. The  Forward Dividend Yield % of Celltrion Inc(XKRX:068270) is 0.25%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |